Deciphering the neurocircuits that initiate counterregulation
Deciphering the neurocircuits that initiate counterregulation
批准号:
9085534
负责人:
Jonathan Nicholas Flak
金额:
$8.97万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2016-12-31
关键词:
AblationAdvisory CommitteesAggressive behaviorAppearanceAreaBlood GlucoseBrainBrain StemCellsCessation of lifeCholecystokininCholecystokinin B ReceptorDataDeoxyglucoseDevelopmentDiabetes MellitusEducational process of instructingEducational workshopEmergency department visitEventExposure toFacultyFailureFoundationsFrightGlucoseGoalsHealthHormonalHyperglycemiaHypoglycemiaIncidenceInsulinInsulin-Dependent Diabetes MellitusLearningLeptinLifeLinkMediatingMetabolicMetabolismMichiganMicrodialysisModelingMusNatureNeuronsNeurosciencesOutputPaperPatientsPharmacogeneticsPlaguePlayPopulationPositioning AttributePublishingRecurrenceRegulationResearchResearch PersonnelResourcesRiskRoleSatiationSeveritiesShockSignal TransductionSiteStimulusSympathetic Nervous SystemSystemTeacher Professional DevelopmentTechniquesTestingTherapeuticTherapeutic InterventionUnited StatesUniversitiesWorkblood glucose regulationcareercostcounterregulationdesigndiabeticdiabetic patienteffective therapyglucose disposalglucose productionhypoglycemia unawarenessin vivoinsulin secretagoguesmolecular markerneural circuitnoveloptogeneticsparabrachial nucleuspost-doctoral trainingpublic health relevancerelating to nervous systemresearch studyresponseskillstargeted treatmenttoolventromedial hypothalamic nucleus
中文摘要
描述(由申请人提供):美国约有2910万患者患有糖尿病(占人口的9.3%),每年花费2450亿美元,在过去五年中增加了40%。这些惊人的数字强调了开发更有效和可能更便宜的糖尿病治疗方法的重要性。虽然糖尿病治疗的目标是血糖正常,但大多数治疗药物(尤其是胰岛素和胰岛素促分泌素)都存在潜在危及生命的低血糖的显著风险;这种风险随着治疗强度的增加而增加。低血糖休克是每年282,000次急诊的原因,每20名1型糖尿病患者中就有1人死亡。除了与低血糖发作相关的经济负担和风险外,低血糖的风险限制了糖尿病治疗。低血糖期间大脑中的低葡萄糖触发反调节反应(CRR),激活交感神经系统(SNS)和刺激葡萄糖产生的激素反应。反复暴露于低血糖可促进低血糖相关自主神经功能衰竭(HAAF)和低血糖无意识,增加低血糖事件的风险和严重程度。因此,了解介导CRR至低血糖的系统至关重要,以便我们可以确定治疗干预的潜在靶点。我的目标是成为一名独立的研究者,研究引发低血糖反调节反应的神经回路。我计划使用本提案中概述的技术来揭示反调节的神经回路,以及该回路中可以调节这些反应的新因素。这些技术(TRAP-seq,光遗传学和体内微透析)与以前收集的工具相结合,将为我提供一套强大的直接电路分析技能。除了在本提案中概述的技术发展,显着的专业发展将发生,因为我过渡到一个独立的教师职位。密歇根大学提供了大量的资源,以研讨会,研讨会和博士后协会,研究学习和教学中心,教师事务和教师发展办公室等提供的短期课程的形式。我还将接受我的职业咨询委员会的指导,他们将帮助我找到一个我将成功担任独立调查员的职位。作为博士后培训的基础(T32和F32支持),我一直在研究瘦素通过脑干部位(主要是臂旁核(PBN))的作用。这些区域含有大量的瘦素反应神经元,直到最近,这些神经元基本上尚未被研究。我们发现,CCK-表达,瘦素和葡萄糖抑制PBN神经元项目腹内侧下丘脑核启动反调节反应,低血糖,胰岛素,2-脱氧葡萄糖的反应,并在高胰岛素/低血糖钳夹。远程激活这些神经元表明,这些神经元可以充分驱动高血糖症和相关的homonal变化和远程抑制这些神经元钝反调节。在这些发表在Nature Neuroscience论文中的研究取得了令人兴奋的结果之后,我们沿着下丘脑腹内侧核(VMN)的回路研究下游神经元,并破译了诱导明显高血糖症的神经回路。VMN将各种代谢参数(包括葡萄糖浓度)与SNS流出和CRR的其他参数联系起来。许多VMN神经元连接到对葡萄糖稳态至关重要的大脑区域。然而,VMN神经元的不同但混合的子集介导不同的效应。事实上,不仅作为CRR的一部分增加葡萄糖产生的神经元存在于VMN中,而且VMN还包含促进葡萄糖处置从而减少循环葡萄糖的神经元。VMN内基本上相反作用的神经元的混合以及缺乏分子标记物来定义CRR-specific亚型的VMN神经元阻碍了我们研究和理解有助于CRR的VMN神经元的能力。由于VMN含有大量的CCK受体B(Cckbr)(又名CCK-2受体)和驱动高血糖的PBN神经元表达CCK,我们产生了Cckbrcre小鼠来研究CCK反应性VMN细胞。我们的初步数据表明,Cckbrcre识别VMN神经元的一个亚群,这些VMNCckbr神经元的药物遗传学激活增加血糖。所提出的实验测试了低葡萄糖激活VMNCckbr神经元的假设,这些神经元投射到介导SNS流出和葡萄糖产生的区域,并且VMNCckbr神经元在低血糖的CRR和HAAF的发作/出现中起核心作用。除了可能揭示CRR背后的神经系统外,这些研究还将定义代谢重要的VMN中一种新型神经元亚群的调节、电路和功能,从而增加我们对控制代谢的大脑系统的理解。通过了解CRR和HAAF的潜在机制,我们将有可能确定对HAAF易感的患者,并仔细进行治疗,同时积极治疗没有这种风险的患者。我们也可能开发出与胰岛素和胰岛素促分泌素共同给药的治疗方法,或者设计出更好的治疗方法,在不诱导糖尿病休克和HAAF的情况下降低血糖。
英文摘要
DESCRIPTION (provided by applicant): Approximately 29.1 million patients in the United States suffer from diabetes (9.3% of the population) costing 245 billion dollars a year, which have increased 40% in the last five years. These staggering figures underscore the importance of developing more effective and potentially cheaper therapeutics for diabetes treatment. While the goal of diabetes treatment is normoglycemia, most therapeutics (especially insulin and insulin secretagogues) carry with them a significant risk of potentially life-threatening hypoglycemia; this risk increases with the intensity of therapy. Hypoglycemic shock is the cause of 282,000 emergency room visits a year and the death of about 1 in every 20 patients with type 1 diabetes. In addition to the financial burden and risk associated with hypoglycemic episodes, the risk of hypoglycemia limits diabetes treatment. Low glucose in the brain during hypoglycemia triggers the counter-regulatory response (CRR), activating the sympathetic nervous system (SNS) and hormonal response that stimulate glucose production. Repeated exposure to hypoglycemia promotes hypoglycemia-associated autonomic failure (HAAF) and hypoglycemia unawareness, increasing the risk and severity of hypoglycemic events. Hence, it will be crucial to understand the systems that mediate the CRR to hypoglycemia so that we may identify potential targets for therapeutic intervention. My goal is to become an independent investigator studying the neurocircuits that initiate the counterregulatory responses to hypoglycemia. I plan to use the techniques outlined in this proposal to reveal the neurocircuitry of counterregulation, as well as novel factors within this circuitry that can regulate these responses. These techniques (TRAP-seq, optogenetics, and in vivo microdialysis) in conjunction with previously gathered tools, will provide me with a strong set of skills for direct circuit analysis. In addition to the technical development outlined in this proposal, significant professional development will take place as I transition into an independent faculty position. The University of Michigan offers a host of resources, in the form of workshops, seminars, and short courses provided by the Postdoctoral Association, Center for Research Learning and Teaching, Office of Faculty Affairs and Faculty Development, among others. I will also receive guidance from my career advisory committee, who will assist me in finding a position that I will be successful at as an independent investigator. As the foundation of postdoctoral training (T32 and F32 support), I have been studying leptin action via brainstem sites (primarily the parabrachial nucleus (PBN)). These areas contain significant populations of leptin responsive neurons that, until recently, have been essentially unstudied. We found that CCK- expressing, leptin and glucose-inhibited PBN neurons project to the ventromedial hypothalamic nucleus to initiate counterregulatory responses to hypoglycemia, revealed by responses to insulin, 2-deoxyglucose, and during a hyperinsulinemic/ hypoglycemic clamp. Remotely activating these neurons revealed that these neurons can sufficiently drive hyperglycemia and associated homonal changes and remotely inhibiting these neurons blunt counterregulation. Following these studies that yielded exciting results published in a Nature Neuroscience paper, we followed the circuit down to the ventromedial hypothalamic nucleus (VMN) to study the downstream neurons and decipher this neurocircuit that induces pronounced hyperglycemia. The VMN links a variety of metabolic parameters (including glucose concentrations) to SNS outflow and other parameters of the CRR. Many VMN neurons connect to brain areas essential to glucose homeostasis. Distinct, but intermingled, subsets of VMN neurons mediate different effects, however. Indeed, not only do neurons that increase glucose production as part of the CRR reside in the VMN, but the VMN also contains neurons that promote glucose disposal and thus decrease circulating glucose. The intermingling of essentially oppositely-acting neurons within the VMN and the lack of molecular markers to define CRR-specific subtypes of VMN neurons has hampered our ability to study and understand the VMN neurons that contribute to the CRR. Since the VMN contains substantial CCK receptor B (Cckbr) (aka CCK-2-receptor) and the PBN neurons that drive hyperglycemia express CCK, we generated Cckbrcre mice to study CCK-responsive VMN cells. Our preliminary data demonstrate that Cckbrcre identifies a subpopulation of VMN neurons, and that pharmacogenetic activation of these VMNCckbr neurons increases blood glucose. The proposed experiments test the hypothesis that low glucose activates VMNCckbr neurons, these neurons project to regions that mediate SNS outflow and glucose production, and VMNCckbr neurons play a central role in the CRR to hypoglycemia and the onset/appearance of HAAF. In addition to potentially revealing a neural system underlying the CRR, these studies will define the regulation, circuitry and function of a novel subpopulation of neurons in the metabolically-important VMN, thereby increasing our understanding of brain systems that control metabolism. By understanding the underlying mechanisms of both the CRR and HAAF, we will potentially determine patients who are susceptible to HAAF and carefully administer treatment, while also aggressively treating patients without such a risk. We may also be able to develop therapeutics to co-administer with insulin and insulin secretagogues or design better therapeutics that will lower blood glucose without inducing diabetic shock and HAAF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the neurocircuit activated by the VMH to control energy expenditure.
-
批准号:10717770
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2023
-
负责人:Jonathan Nicholas Flak
-
依托单位:
Brainstem LepRb neurons in the control of metabolism
-
批准号:8521715
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2013
-
负责人:Jonathan Nicholas Flak
-
依托单位:
海外基金